SYSTEMIC ADMINISTRATION OF CCK-8S, BUT NOT CCK-4, ENHANCES DOPAMINE TURNOVER IN THE POSTERIOR NUCLEUS-ACCUMBENS - A MICRODIALYSIS STUDY IN FREELY MOVING RATS

被引:14
作者
KARIYA, K
TANAKA, J
NOMURA, M
机构
[1] Department of Physiology, Saitama Medical School, Iruma-gun, Saitama, 350-04, 38 Morohongo, Moroyama
关键词
CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ TETRAPEPTIDE; NUCLEUS ACCUMBENS; CAUDATE-PUTAMEN; DOPAMINE; DIHYDROXYPHENYLACETIC ACID; HOMOVANILLIC ACID; IN VIVO MICRODIALYSIS; RAT;
D O I
10.1016/0006-8993(94)90946-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study was carried out to examine the effects of peripheral administration of sulfatedcholecystokinin octapeptide (CCK-8S) on dopamine (DA) turnover in the posterior nucleus accumbens (PNAc) and the caudate-putamen (CP) in awake rats. Microdialysis was used to quantify the extracellular concentrations of DA and its two metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Intraperitoneal injections of CCK-8S (0.3 mg/kg b.wt.) caused a significant increase in DOPAC and HVA concentrations in the PNAc, but did not affect the DA level. Such increases in the metabolite contents were not found in the CP. Similar injections of vehicle (1% NaHCO3 solution, 1 ml/kg b.wt.) did not have an effect in either brain region. In an attempt to determine the type of receptor involved in the CCK-8S-induced changes, CCK tetrapeptide (CCK-4, 0.3 mg/kg b.wt.) known to have high affinity for CCKB subtype or vehicle (10% DMSO-saline, 1 ml/kg b.wt.) was administered intraperitoneally. Neither CCK-4 nor vehicle caused significant changes in any of extracellular DA, DOPAC and HVA contents in the PNAc. These results suggest that peripherally administered CCK-8S has stimulatory effects on the dopaminergic system in the PNAc, and raise the possibility that the effect appears to be mediated via CCKA receptors.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 44 条
  • [1] BRAIN CCK-B RECEPTORS MEDIATE THE SUPPRESSION OF DOPAMINE RELEASE BY CHOLECYSTOKININ
    ALTAR, CA
    BOYAR, WC
    [J]. BRAIN RESEARCH, 1989, 483 (02) : 321 - 326
  • [2] STRIATAL LESIONS AND TRANSPLANTS DEMONSTRATE THAT CHOLECYSTOKININ RECEPTORS ARE LOCALIZED ON INTRINSIC STRIATAL NEURONS - A QUANTITATIVE AUTORADIOGRAPHIC STUDY
    BERESFORD, IJM
    HALL, MD
    CLARK, CR
    HILL, RG
    HUGHES, J
    SIRINATHSINGHJI, DJS
    [J]. NEUROPEPTIDES, 1987, 10 (02) : 109 - 136
  • [3] CRAWLEY JN, 1992, J NEUROSCI, V12, P3380
  • [5] CHARACTERIZATION OF [H-3] CCK4 BINDING-SITES IN MOUSE AND RAT-BRAIN
    DURIEUX, C
    PELAPRAT, D
    CHARPENTIER, B
    MORGAT, JL
    ROQUES, BP
    [J]. NEUROPEPTIDES, 1988, 12 (03) : 141 - 148
  • [6] INFLUENCE OF CHOLECYSTOKININ OCTAPEPTIDE SULFATE ESTER ON BRAIN MONOAMINE METABOLISM IN RATS
    FEKETE, M
    KADAR, T
    PENKE, B
    KOVACS, K
    TELEGDY, G
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1981, 50 (2-4) : 81 - 88
  • [7] MESOCORTICOLIMBIC DOPAMINE SYSTEMS AND REWARD
    FIBIGER, HC
    PHILLIPS, AG
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 537 : 206 - 215
  • [8] CHOLECYSTOKININ PEPTIDES PRODUCE MARKED REDUCTION OF DOPAMINE TURNOVER IN DISCRETE AREAS IN THE RAT-BRAIN FOLLOWING INTRAVENTRICULAR-INJECTION
    FUXE, K
    ANDERSSON, K
    LOCATELLI, V
    AGNATI, LF
    HOKFELT, T
    SKIRBOLL, L
    MUTT, V
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 67 (2-3) : 329 - 331
  • [9] LOCALIZATION OF CHOLECYSTOKININ RECEPTORS IN RELATION TO THE NIGROSTRIATAL AND MESOLIMBIC DOPAMINERGIC PATHWAYS
    GAUDREAU, P
    QUIRION, R
    STPIERRE, S
    CHIUEH, CC
    PERT, A
    [J]. NEUROPEPTIDES, 1987, 9 (04) : 283 - 293
  • [10] HILL DR, 1987, J NEUROSCI, V7, P2967